When a symptomatic patient is currently taking a drug known to elevate prolactin, medication-induced hyperprolactinemia becomes the primary diagnostic consideration. The clinical approach turns on whether that medication can be safely modified.
The patient presents with symptoms of hyperprolactinemia and is actively using a medication associated with prolactin elevation. Establishing the drug as the likely cause — before pursuing other workup or treatment — is central to management.
When medication adjustment is not possible, a specific class of agents — dopamine agonists — may be considered in selected cases, under close specialist guidance. The full decision pathway, including when and how this applies, is detailed in the structured protocol.
DOI: 10.1210/jc.2010-1692